INBS Intelligent Bio Solutions Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 19, 2026
$1.66
· of 52w range
· above low
· to high
$0.6452w low
$24.9052w high
Market Cap (MRQ)
$5M
P/E (TTM)
-0.2
EPS (TTM)
$-8.44
Revenue (TTM)
$4M
your badges
52W Range
$1–$25
Analyst Rating
STRONG BUY
Price Target
$12
P/E
-0.2
ROE
-292.3%
Net Profit Margin
-294.9%
Your badge strip is empty — pin a metric anywhere on this page.
INBS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.66
Market Cap (MRQ)
$5M
P/E (TTM)
-0.2
EPS (TTM)
$-8.44
Revenue (TTM)
$4M
ROE (TTM)
-292.3%
52W Range
$1–$25
INBS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Dec. 16, 2025 | 1-for-10 | Reverse |
| Jan. 29, 2024 | 1-for-12 | Reverse |
| Feb. 10, 2023 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$4M2020-06-30 → 2026-06-30
EPS$-8.442022-06-30 → 2026-06-30
Free Cash Flow$-12M2025-06-30 → 2026-06-30
Net margin-294.9%2023-06-30 → 2026-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | INBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -0.25Y avg ≈-3.1 | ≈-3.1 | · | · | |
| P/S (TTM) | 1.15Y avg ≈22.5 | ≈22.5 | 3.9 | Undervalued | |
| P/B (MRQ) | 0.95Y avg ≈8.6 | ≈8.6 | 1.2 | Fair value | |
| Price / FCF (TTM) | -0.4 | · | · | · | |
| Price / Cash Flow (TTM) | -0.45Y avg ≈-4.1 | ≈-4.1 | · | · | |
| Price / Tangible Book (MRQ) | 1.85Y avg ≈120.4 | ≈120.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | INBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 48.6%5Y avg ≈38.5% | ≈38.5% | · | · | |
| Operating Margin (TTM) | -299.1%5Y avg ≈-550.0% | ≈-550.0% | -2015.8% | Top tier | |
| EBITDA Margin | -299.1%5Y avg ≈-517.8% | ≈-517.8% | -2015.8% | Top tier | |
| Net Profit Margin (TTM) | -294.9%5Y avg ≈-495.7% | ≈-495.7% | -2038.7% | Top tier | |
| ROA (TTM) | -123.1%5Y avg ≈-104.2% | ≈-104.2% | -114.7% | In line | |
| ROE (TTM) | -292.3%5Y avg ≈-227.6% | ≈-227.6% | -160.6% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | INBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.45Y avg ≈1.0 | ≈1.0 | 3.2 | Low liquidity | |
| Quick Ratio | 1.05Y avg ≈0.5 | ≈0.5 | 1.8 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | INBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 38.1%5Y avg ≈58.7% | ≈58.7% | · | · | |
| Revenue CAGR 3Y | 49.7%5Y avg ≈61.3% | ≈61.3% | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | INBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.3 | ≈0.3 | 0.1 | Top tier | |
| Inventory Turnover | 4.15Y avg ≈2.9 | ≈2.9 | 1.7 | Top tier | |
| Receivables Turnover | 5.85Y avg ≈6.8 | ≈6.8 | 5.9 | Weak | |
| Revenue / Employee | ≈$71.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-20.4%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Dec. 31, 2026 | Aug 19, 2026 | $-0.90 | $-1.61 | 44.2% |
| June 30, 2026 | $-0.90 | $-1.61 | 44.2% | |
| Sept. 30, 2024 | $-7.00 | $-5.41 | -29.5% | |
| June 30, 2024 | $-13.40 | $-5.20 | -157.6% | |
| March 31, 2024 | $-14.30 | $-8.87 | -61.1% | |
| Dec. 31, 2023 | $-20.70 | $-33.05 | 37.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $3M | $3M | $1M | · | $2M | $188.7K | |
| Cost of Revenue | $2M | $2M | $2M | $930.2K | · | · | · | |
| Gross Profit | $2M | $1M | $1M | $326.7K | · | · | · | |
| SG&A Expense | $11M | $9M | $9M | $8M | $5M | $3M | $2M | |
| Operating Expenses | $15M | $13M | $12M | $14M | $9M | $8M | $3M | |
| Operating Income | $-13M | $-11M | $-10M | $-13M | $-8M | $-6M | $-3M | |
| Interest Income | $110.3K | $101.5K | $84.8K | · | · | · | · | |
| Other Non-op | $139.4K | $74.3K | $92.2K | $2M | $2.9K | $-1M | $-336.0K | |
| Pretax Income | · | · | · | · | · | $-7M | $-3M | |
| Net Income | $-12M | $-11M | $-10M | $-11M | $-8M | $-7M | $-3M | |
| EPS (Basic) | $-8.44 | $-20.04 | $-6.38 | $-127.00 | $-11.33 | $-0.68 | · | |
| EPS (Diluted) | $-8.44 | $-20.04 | $-6.38 | $-127.00 | $-11.33 | · | · | |
| Shares (Basic) | 1,472,744 | 527,364 | 1,592,746 | 83,717 | 733,263 | 10,414,886 | · | |
| Shares (Diluted) | 1,472,744 | 527,364 | 1,592,746 | 83,717 | 733,263 | · | · | |
| EBITDA | $-13M | $-10M | · | $-12M | · | · | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $1M | $6M | $2M | $8M | $13M | $427.3K | |
| Receivables | $848.5K | $594.6K | $429.7K | $293.9K | · | · | · | |
| Inventory | $418.6K | $635.2K | $777.5K | $979.9K | · | · | · | |
| Prepaid Expense | $1M | $827.0K | $363.1K | $360.0K | $116.5K | $2M | $29.5K | |
| Other Current Assets | $1M | $827.0K | $497.6K | $552.8K | $746.8K | $3M | $49.1K | |
| Current Assets | $7M | $4M | $9M | $4M | $11M | $18M | $2M | |
| PP&E (Net) | $294.4K | $251.3K | $565.9K | $690.2K | $391.4K | · | · | |
| PP&E (Gross) | $449.1K | $339.5K | $626.6K | $723.9K | $391.4K | · | · | |
| Accum. Depreciation | $154.7K | $88.2K | $60.8K | $33.8K | · | · | · | |
| Intangibles | $3M | $4M | $4M | $5M | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | $504.0K | · | |
| Total Assets | $12M | $8M | $14M | $10M | $12M | $22M | $2M | |
| Accounts Payable | $712.4K | $897.3K | $2M | $3M | $2M | $1M | $787.5K | |
| Accrued Liabilities | · | $1M | $607.2K | $777.1K | $909.2K | · | · | |
| Short-term Debt | · | $197.1K | $515.3K | $353.2K | · | · | · | |
| Current Liabilities | $5M | $5M | $5M | $6M | $5M | $4M | $8M | |
| Capital Leases | $2M | · | $81.3K | $356.2K | · | · | · | |
| Total Liabilities | $7M | $5M | $6M | $7M | $6M | $7M | $8M | |
| Total Debt | · | $197.1K | · | $353.2K | · | · | · | |
| Common Stock | $29.1K | $7.3K | $34.6K | $1.9K | $7.4K | $135.8K | $86.3K | |
| Paid-in Capital | $81M | $66M | $61M | $46M | $39M | $38M | $11M | |
| Retained Earnings | $-75M | $-63M | $-52M | $-42M | $-31M | $-23M | $-16M | |
| Treasury Stock | $1 | $1 | $1 | $1 | · | · | · | |
| AOCI | $-546.2K | $-327.9K | $-712.6K | $-575.5K | $-788.1K | $-661.3K | $-364.0K | |
| Stockholders' Equity | $6M | $3M | $8M | $4M | $7M | $15M | $-5M | |
| Liabilities + Equity | $12M | $8M | $14M | $10M | $12M | $22M | $2M | |
| Shares Outstanding | 2,905,603 | 732,327 | 3,456,000 | 194,200 | 744,496 | 13,582,122 | 8,630,000 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $970.1K | $974.4K | $814.5K | · | · | · | |
| Stock-based Comp | $195.2K | $238.0K | $230.5K | $260.0K | · | · | · | |
| Amort. of Intangibles | $1M | $949.3K | $947.4K | $805.8K | $0 | · | · | |
| Other Non-cash | · | $-316.7K | · | $2M | · | · | · | |
| Operating Cash Flow | $-12M | $-10M | $-10M | $-7M | $-3M | $-11M | $-498.6K | |
| CapEx | $125.7K | $231.8K | $221.4K | · | · | · | · | |
| Investing Cash Flow | $-85.6K | $-231.8K | $-221.4K | $-694.1K | $-880.2K | · | $-14.0K | |
| Stock Issued | · | · | · | · | · | $508.3K | · | |
| Financing Cash Flow | $15M | $5M | $15M | $1M | · | $23M | $733.9K | |
| Net Change in Cash | $3M | $-5M | $5M | $-7M | $-4M | $12M | $229.3K | |
| Free Cash Flow | $-12M | $-10M | · | · | · | · | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.6% | 40.8% | · | 26.0% | · | · | · | |
| Operating Margin | -299.1% | -348.7% | · | -1002.1% | · | · | · | |
| Net Margin | -294.9% | -346.2% | · | -845.9% | · | · | · | |
| EBITDA Margin | -299.1% | -316.9% | · | -937.3% | · | · | · | |
| ROA | -123.1% | -96.0% | · | -93.6% | · | · | · | |
| ROE | -292.2% | -186.6% | · | -204.0% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 0.8 | · | 0.7 | · | · | · | |
| Quick Ratio | 1.0 | 0.3 | · | 0.3 | · | · | · | |
| Debt / Equity | · | 0.1 | · | 0.1 | · | · | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | · | 0.1 | · | · | · | |
| Inventory Turnover | 4.1 | 2.6 | · | 1.9 | · | · | · | |
| Receivables Turnover | 5.8 | 6.0 | · | 8.6 | · | · | · |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.90 | $0.41 | · | $1.63 | · | · | · | |
| Revenue / Share | $2.86 | $0.58 | · | $1.25 | · | · | · | |
| Cash Flow / Share | $-8.10 | $-1.83 | · | $-7.34 | · | · | · | |
| Cash / Share | $1.37 | $0.14 | · | $0.66 | · | · | · | |
| EPS (TTM) | $-8.44 | $-2.00 | $-6.38 | $-127.00 | $-11.33 | · | · |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 38.1% | -1.9% | 147.6% | 187.5% | -77.9% | 949.3% | · | |
| Revenue CAGR 3Y | 49.7% | 91.1% | 16.3% | 88.1% | · | · | · | |
| Revenue CAGR 5Y | 16.3% | 74.5% | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $3M | $3M | $1M | $371.2K | $2M | · | |
| Net Income TTM | $-12M | $-11M | $-10M | $-11M | $-8M | $-7M | · | |
| Market Cap | $7M | $13M | · | $78M | · | · | · | |
| Enterprise Value | · | $12M | · | $77M | · | · | · | |
| P/E | -0.3 | -0.9 | -0.3 | -0.3 | -14.0 | · | · | |
| P/S | 1.6 | 4.1 | · | 61.9 | · | · | · | |
| P/B | 1.2 | 4.2 | · | 20.5 | · | · | · | |
| P / Tangible Book | 2.5 | · | 1.7 | · | 357.1 | 852.9 | · | |
| P / Cash Flow | -0.6 | -1.3 | · | -10.5 | · | · | · | |
| P / FCF | -0.6 | -1.3 | · | · | · | · | · | |
| EV / EBITDA | · | -1.2 | · | -6.5 | · | · | · | |
| EV / FCF | · | -1.2 | · | · | · | · | · | |
| EV / Revenue | · | 3.9 | · | 60.9 | · | · | · | |
| Earnings Yield | -367.8% | -116.3% | -332.3% | -380.7% | -7.1% | · | · |
Income Statement
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $1M | $896.8K | $1M | $843.9K | $728.9K | $607.5K | $872.3K | $380.9K | $907.6K | $917.3K | $906.0K | $131.8K | $457.1K | $356.7K | · | |
| Cost of Revenue | $609.2K | $525.4K | $437.0K | $593.5K | $508.3K | $387.5K | $384.4K | $525.5K | $-87.7K | $645.3K | $564.8K | $563.8K | $393.6K | $424.0K | $112.6K | · | |
| Gross Profit | $536.6K | $535.4K | $459.7K | $518.3K | $335.6K | $341.4K | $223.1K | $346.8K | $815.6K | $178.5K | $199.2K | $232.3K | $49.6K | $33.0K | $244.0K | · | |
| SG&A Expense | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Operating Expenses | $5M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $2M | $3M | $3M | $7M | $3M | $2M | |
| Operating Income | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-7M | $-2M | $-1M | |
| Interest Income | $47.0K | $49.4K | $5.3K | $8.5K | $9.1K | $17.7K | $21.9K | $52.8K | $70.5K | $10.6K | $3.5K | $139 | · | · | · | · | |
| Other Non-op | $108.2K | $77.5K | $-50.9K | $4.6K | $26.5K | $9.7K | $7.7K | $30.5K | $16.4K | $-33.0K | $15.0K | $93.9K | $31.1K | $191.4K | $2M | $4.3K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $-6M | · | · | |
| Net Income | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-6M | $-420.6K | $-1M | |
| EPS (Basic) | $-3.47 | $-1.80 | $-2.82 | $-0.35 | $-9.97 | $-4.41 | $-4.96 | $-0.70 | $9.60 | $-1.43 | $-2.07 | $-12.48 | $-51.15 | $-68.67 | $-5.56 | $-1.62 | |
| EPS (Diluted) | $-3.47 | $-1.80 | $-2.82 | $-0.35 | $-9.97 | $-4.41 | $-4.96 | $-0.70 | $9.60 | $-1.43 | $-2.07 | $-12.48 | $-51.15 | $-68.67 | $-5.56 | $-1.62 | |
| Shares (Basic) | · | 1,594,496 | 950,829 | 8,546,934 | · | 577,191 | 453,582 | 3,811,090 | · | 2,079,864 | 949,660 | 194,200 | · | 92,389 | 75,690 | 14,889,904 | |
| Shares (Diluted) | · | 1,594,496 | 950,829 | 8,546,934 | · | 577,191 | 453,582 | 3,811,090 | · | 2,079,864 | 949,660 | 194,200 | · | 92,389 | 75,690 | 744,495 | |
| EBITDA | · | $-3M | $-3M | $-3M | · | $-3M | $-2M | $-2M | · | $-3M | $-2M | $-2M | · | $-7M | $-2M | $-1M |
Balance Sheet
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $7M | $740.4K | $2M | $1M | $3M | $2M | $4M | $6M | $9M | $1M | $186.4K | $2M | $2M | $3M | $6M | |
| Receivables | $848.5K | $878.4K | $456.7K | $717.8K | $594.6K | $511.0K | $266.1K | $578.6K | $429.7K | $431.6K | $262.8K | $567.5K | $293.9K | $296.0K | $278.3K | · | |
| Inventory | $418.6K | $597.5K | $590.2K | $628.2K | $635.2K | $683.5K | $701.3K | $738.8K | $777.5K | $877.9K | $942.0K | $965.1K | $979.9K | $736.2K | $671.0K | · | |
| Prepaid Expense | $1M | $843.1K | · | · | $827.0K | · | · | · | $363.1K | · | · | · | $360.0K | $390.5K | $329.8K | $41.5K | |
| Other Current Assets | $1M | · | $480.1K | $488.2K | $827.0K | $585.5K | $348.7K | $396.2K | $497.6K | $481.0K | $331.6K | $413.3K | $552.8K | $531.8K | $521.9K | $148.9K | |
| Current Assets | $7M | $10M | $12M | $4M | $4M | $5M | $4M | $6M | $9M | $12M | $3M | $3M | $4M | $4M | $6M | $8M | |
| PP&E (Net) | $294.4K | $312.3K | $321.7K | $271.7K | $251.3K | $546.5K | $537.2K | $586.1K | $565.9K | $559.5K | $591.3K | $664.9K | $690.2K | $478.1K | $484.3K | $416.0K | |
| PP&E (Gross) | $449.1K | · | · | · | $339.5K | · | · | · | $626.6K | · | · | · | $723.9K | $494.0K | $493.8K | · | |
| Accum. Depreciation | $154.7K | · | · | · | $88.2K | · | · | · | $60.8K | · | · | · | $33.8K | $15.9K | $9.5K | $416.0K | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | · | |
| Intangibles | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $504.9K | |
| Total Assets | $12M | $15M | $18M | $10M | $8M | $10M | $9M | $12M | $14M | $17M | $9M | $9M | $10M | $11M | $18M | $10M | |
| Accounts Payable | $712.4K | $4M | $4M | $4M | $897.3K | $1M | $1M | $2M | $2M | $2M | $2M | $4M | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | · | · | · | · | $1M | · | · | · | $607.2K | · | · | · | $777.1K | $385.7K | $309.5K | · | |
| Short-term Debt | · | · | $13.0K | $139.8K | $197.1K | $356.2K | $405.5K | $499.6K | $515.3K | $368.5K | $370.5K | $341.8K | $353.2K | $335.5K | $326.0K | · | |
| Current Liabilities | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $6M | $5M | $6M | $5M | $7M | $6M | $4M | $5M | $2M | |
| Capital Leases | $2M | $1M | $2M | $1M | · | $3.7K | $14.5K | $28.1K | $81.3K | $154.2K | $228.7K | $284.0K | $356.2K | · | · | · | |
| Total Liabilities | $7M | $6M | $7M | $7M | $5M | $5M | $4M | $6M | $6M | $6M | $6M | $7M | $7M | $5M | $8M | $5M | |
| Total Debt | · | · | $13.0K | $139.8K | · | $356.2K | $405.5K | $499.6K | · | $368.5K | $370.5K | $341.8K | · | $335.5K | $326.0K | · | |
| Common Stock | $29.1K | $20.0K | $12.4K | $91.0K | $7.3K | $67.9K | $48.1K | $43.8K | $34.6K | $29.1K | $14.8K | $23.3K | $1.9K | $16.9K | $9.2K | $148.9K | |
| Paid-in Capital | $81M | $80M | $80M | $69M | $66M | $65M | $62M | $61M | $61M | $61M | $50M | $46M | $46M | $46M | $44M | $38M | |
| Retained Earnings | $-75M | $-71M | $-68M | $-66M | $-63M | $-59M | $-57M | $-55M | $-52M | $-49M | $-46M | $-44M | $-42M | $-39M | $-33M | $-32M | |
| Treasury Stock | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $14 | $1 | $14 | $14 | · | |
| AOCI | $-546.2K | $-499.7K | $-266.1K | $-279.2K | $-327.9K | $-523.4K | $-639.4K | $-496.3K | $-712.6K | $-662.4K | $-518.4K | $-593.5K | $-575.5K | $-639.9K | $-562.1K | $-923.7K | |
| Stockholders' Equity | $6M | $9M | $11M | $4M | $3M | $5M | $4M | $6M | $8M | $11M | $3M | $1M | $4M | $6M | $10M | $5M | |
| Liabilities + Equity | $12M | $15M | $18M | $10M | $8M | $10M | $9M | $12M | $14M | $17M | $9M | $9M | $10M | $11M | $18M | $10M | |
| Shares Outstanding | 2,905,603 | 2,001,173 | 1,238,434 | 9,098,357 | 732,327 | 6,794,395 | 4,807,068 | 4,377,759 | 3,456,000 | 2,913,799 | 1,476,042 | 2,330,399 | 194,200 | 1,685,467 | 917,650 | 14,889,904 |
Cash Flow
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $288.2K | $290.4K | $327.4K | $257.9K | $243.9K | $237.5K | $369.1K | $241.6K | $227.8K | $267.5K | $231.4K | $247.6K | $112.0K | $353.0K | $398.2K | · | |
| Stock-based Comp | $97.4K | $24.2K | $61.6K | $12.0K | $12.0K | $12.0K | $12.0K | $202.0K | $12.2K | $218.3K | · | · | $0 | $0 | $260.0K | · | |
| Amort. of Intangibles | $482.3K | $215.6K | $212.2K | $242.4K | $234.1K | $238.9K | $240.8K | $235.5K | $221.3K | $255.5K | $227.5K | $243.2K | $119.2K | $346.5K | $340.0K | $0 | |
| Other Non-cash | · | · | · | $-133.7K | · | · | · | $-145.2K | · | · | · | $865.8K | · | · | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-2M | $-3M | $-2M | $-3M | $-2M | $-2M | $-3M | $-2M | $-3M | $-1M | $-584.3K | $-3M | $-2M | $-2M | |
| CapEx | $0 | $-12.9K | $68.2K | $70.4K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $0 | $12.9K | $-28.1K | $-70.4K | $-208.5K | $-14.4K | · | · | $-167.3K | $2.6K | · | · | $-181.8K | $173.8K | $-211.3K | $-474.9K | |
| Stock Issued | · | · | · | · | · | $809.7K | $676.6K | $34.5K | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $809.7K | $676.6K | $34.5K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $312.0K | $10M | $674.7K | $4M | $602.0K | $3M | $631.7K | $42.5K | $5.3K | $11M | · | · | $46.1K | $2M | · | · | |
| Net Change in Cash | $-3M | $6M | $-919.7K | $640.2K | $-2M | $564.9K | $-2M | $-2M | $-3M | $8M | $932.6K | $-1M | $-743.3K | $-631.1K | $-3M | $-2M | |
| Free Cash Flow | · | · | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 50.5% | 51.3% | 46.6% | · | 37.8% | 30.1% | 34.7% | · | 21.7% | 26.1% | 29.2% | · | 7.2% | 68.4% | · | |
| Operating Margin | · | -277.8% | -293.9% | -269.8% | · | -283.0% | -305.5% | -273.0% | · | -358.6% | -260.6% | -317.4% | · | -1431.6% | -597.5% | -391.4% | |
| Net Margin | · | -269.9% | -298.6% | -268.3% | · | -281.9% | -303.5% | -269.0% | · | -361.5% | -257.8% | -304.6% | · | -1388.0% | -117.9% | -388.1% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -1389.8% | · | · | |
| EBITDA Margin | · | -277.8% | -293.9% | -246.6% | · | -283.0% | -305.5% | -248.8% | · | -358.6% | -260.6% | -286.2% | · | -1431.6% | -597.5% | -391.4% | |
| ROA | · | -23.4% | -20.3% | -27.4% | · | -19.1% | -25.7% | -26.3% | · | -21.5% | -14.7% | -25.7% | · | -50.7% | -2.5% | -8.3% | |
| ROE | · | -40.7% | -34.6% | -61.3% | · | -31.3% | -58.8% | -72.0% | · | -34.7% | -28.9% | -73.1% | · | -85.7% | -4.1% | -12.8% |
Liquidity & Solvency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.1 | 2.4 | 0.9 | · | 1.1 | 0.9 | 1.1 | · | 2.0 | 0.6 | 0.4 | · | 1.3 | 1.3 | 3.5 | |
| Quick Ratio | · | 1.7 | 0.2 | 0.5 | · | 0.7 | 0.6 | 0.8 | · | 1.7 | 0.3 | 0.1 | · | 0.7 | 0.7 | 2.4 | |
| Debt / Equity | · | · | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.3 | · | 0.1 | 0.0 | · |
Efficiency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | 0.8 | 0.7 | 0.9 | · | 0.5 | 0.5 | 0.6 | · | 0.8 | 0.7 | 1.2 | · | 1.2 | 0.3 | · | |
| Receivables Turnover | · | 1.5 | 2.5 | 1.7 | · | 1.9 | 2.8 | 1.7 | · | 2.3 | 2.8 | 2.8 | · | 3.1 | 2.6 | · |
Per Share
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $4.48 | $8.96 | $0.40 | · | $0.75 | $0.91 | $1.39 | · | $3.82 | $2.22 | $0.58 | · | $3.58 | $11.28 | $0.35 | |
| Revenue / Share | · | $0.67 | $0.94 | $0.13 | · | $0.16 | $0.16 | $0.26 | · | $0.40 | $0.80 | $0.34 | · | · | · | · | |
| Cash Flow / Share | · | · | · | $-0.33 | · | · | · | $-0.63 | · | · | · | $-0.56 | · | · | · | · | |
| Cash / Share | · | $3.43 | $0.60 | $0.18 | · | $0.41 | $0.47 | $0.91 | · | $3.23 | $0.76 | $0.08 | · | $1.35 | $3.17 | $0.39 | |
| EPS (TTM) | · | $-14.94 | $-17.55 | $-19.69 | · | $-0.47 | $2.51 | $5.40 | · | $-67.13 | $-134.37 | $-137.86 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $4M | $4M | $3M | · | $3M | $3M | $3M | · | $3M | $2M | $2M | · | · | · | $2M | |
| Net Income TTM | · | $-12M | $-11M | $-11M | · | $-10M | $-11M | $-10M | · | $-10M | $-13M | $-12M | · | $-10M | $-5M | $-8M | |
| Market Cap | · | $7M | $12M | $9M | · | $10M | $7M | $8M | · | $12M | $6M | $29M | · | $59M | $44M | $1.50B | |
| Enterprise Value | · | · | $11M | $8M | · | $7M | $5M | $4M | · | $3M | $5M | $29M | · | $57M | $41M | · | |
| P/E | · | -0.2 | -0.5 | -0.1 | · | -3.1 | 0.6 | 0.3 | · | -0.1 | -0.0 | -0.1 | · | · | · | · | |
| P/S | · | 1.7 | 3.3 | 2.8 | · | 3.8 | 2.4 | 2.5 | · | 4.3 | 2.5 | 15.6 | · | · | · | 757.8 | |
| P/B | · | 0.7 | 1.1 | 2.6 | · | 1.9 | 1.5 | 1.2 | · | 1.1 | 1.8 | 21.2 | · | 9.7 | 4.3 | 284.2 | |
| P / Tangible Book | · | 1.1 | 1.5 | 62.7 | · | 7.5 | 14.5 | 4.4 | · | 1.9 | · | · | · | 80.2 | 58.6 | 284.2 | |
| P / Cash Flow | · | · | · | -3.3 | · | · | · | -3.2 | · | · | · | -22.0 | · | · | · | -792.6 | |
| EV / Revenue | · | · | 3.1 | 2.4 | · | 2.8 | 1.8 | 1.3 | · | 1.1 | 2.2 | 15.6 | · | · | · | · | |
| Earnings Yield | · | -446.6% | -184.2% | -1930.4% | · | -32.6% | 179.3% | 312.1% | · | -1590.8% | -3312.9% | -1115.4% | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Revenue | $4M | $3M | $3M | $1M | · |
| Gross Margin % | 48.6% | 40.8% | · | 26.0% | · |
| Operating Margin % | -299.1% | -348.7% | · | -1002.1% | · |
| Net Income | $-12M | $-11M | $-10M | $-11M | $-8M |
| Diluted EPS | $-8.44 | $-20.04 | $-6.38 | $-127.00 | $-11.33 |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Debt / Equity | · | 0.1 | · | 0.1 | · |
| Current Ratio | 1.4 | 0.8 | · | 0.7 | · |
| Quick Ratio | 1.0 | 0.3 | · | 0.3 | · |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $-12M | $-10M | · | · | · |
Institutional owners (13F) 8 filers · $416K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
8
Value held
$416K
New positions
1
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 1 (-5 vs prior Q) | 2 (-2 vs prior Q) | 3 (+3 vs prior Q) | 1 (-1 vs prior Q) | -27K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $324,506 | 141,397 | 77.96% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $47,827 | 20,840 | 11.49% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $13,334 | 5,810 | 3.20% | Shares |
| UBS Group AG | $13,162 | 5,735 | 3.16% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $9,084 | 3,958 | 2.18% | Shares |
| Tower Research Capital LLC (TRC) | $7,528 | 3,280 | 1.81% | Shares |
| OSAIC HOLDINGS, INC. | $460 | 200 | 0.11% | Shares |
| BARCLAYS PLC | $326 | 142 | 0.08% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Gary W. Rollins, The Gary W. Rollins Foundation, The Ma-Ran Foundation | June 1, 2023 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 12 insiders · 2 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Harry Simeonidis | Chief Executive Officer | March 18, 2026 A | 34,540 | 0 | 0 | $0 |
| Spiro Kevin Sakiris | Chief Financial Officer | March 18, 2026 A | 33,981 | 0 | 0 | $0 |
| Nicola Marion Fraser | Director | March 18, 2026 A | 5,000 | 0 | 0 | $0 |
| Jason Isenberg | Director | March 18, 2026 A | 5,000 | 0 | 0 | $0 |
| Jonathan Scott Hurd | Director | March 18, 2026 A | 5,006 | 0 | 0 | $0 |
| Steven Constantine Boyages | Director | March 18, 2026 A | 5,031 | 0 | 0 | $0 |
| Christopher Towers | Director | Oct. 4, 2023 P | 9,880 | 0 | 0 | $0 |
| George Margelis | Director | Oct. 10, 2022 A | 15,000 | 0 | 0 | $0 |
| Lawrence B Fisher | Director | Oct. 10, 2022 A | 15,000 | 0 | 0 | $0 |
| Tom Parmakellis | Director | Dec. 30, 2021 P | 9,300 | 0 | 0 | $0 |
| Victoria Gavrilenko | Director | March 2, 2021 P | 37 | 0 | 0 | $0 |
| Life Science Biosensor Diagnostics Pty Ltd | · | Feb. 17, 2022 S | 1,081,804 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 5,810 SH | Aug. 19, 2026 | Daily |
INBS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$12.00
+622.9%
3 42.9%
Strong Buy
3 42.9%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-20Mean target $12.00 +622.9%
Low$12.00
Mean$12.00
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| INBS | $7M | -0.3 | 38.1% | -294.9% | -292.2% | 48.6% |
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| CODX | $11M | -0.1 | -84.1% | -7533.6% | -151.8% | 64.3% |
| AMIX | · | · | · | · | · | · |
| NVNO | $210.6K | -0.0 | · | · | -64.7% | · |
| NXL | $11M | -1.1 | 78.8% | -2725.8% | -169.3% | 79.7% |
| TNON | · | · | · | · | · | · |
| IVF | · | -0.0 | 4.7% | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-K filed Aug 19, 2026